Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I Trial To Evaluate The Safety Of CK0801 In Treatment-Resistant Guillain-Barré Syndrome (GBS)

Trial Profile

Phase I Trial To Evaluate The Safety Of CK0801 In Treatment-Resistant Guillain-Barré Syndrome (GBS)

Suspended
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2019

At a glance

  • Drugs CK 0801 (Primary)
  • Indications Guillain-Barre syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Feb 2019 Planned initiation date changed from 1 Jan 2019 to 1 Mar 2019.
    • 06 Feb 2019 Status changed from not yet recruiting to suspended due to Pending contract negotiations..
    • 10 Dec 2018 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top